|
LLY
Eli Lilly and
|
28 | |
|
Dermira
|
1 | |
|
LOXO
Loxo Oncology
|
1 | |
|
DICE
DICE Therapeutics
|
1 | |
|
MORF
Morphic Holding
|
1 | |
|
ARMO
ARMO BioSciences
Inactive
|
1 | |
|
AKUS
Akouos
|
1 | |
|
PNT
POINT Biopharma Global
|
1 |
| 10-K | 9 | |
| SC TO-T | 7 | |
| SD | 6 | |
| 424B2 | 2 | |
| 10-Q | 1 | |
| CORRESP | 1 | |
| DEF 14A | 1 | |
| PRE 14A | 1 |
